Abstract: Introduction UK public health policy emphasises the need for increased influenza vaccination during the COVID-19 pandemic. However, there are claims on social media that influenza vaccination increases risk of adverse outcomes in SARS-CoV-2 infection that may compromise uptake, especially in high risk groups such as those with airways disease. There is also emerging evidence that inhaled corticosteroids (ICS) may modify this risk. We therefore sought to urgently assess the risk of morbidity and mortality in individuals admitted with COVID-19, a...
(read more)
Topics: 
Internal medicine
Pediatrics
Immunology